Detalhe da pesquisa
1.
Immunotherapy in unresectable stage III non-small-cell lung cancer: state of the art and novel therapeutic approaches.
Ann Oncol
; 33(9): 893-908, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35777706
2.
ESMO expert consensus statements on the management of EGFR mutant non-small-cell lung cancer.
Ann Oncol
; 33(5): 466-487, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35176458
3.
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with locally-advanced unresectable non-small-cell lung cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS.
Ann Oncol
; 31(2): 191-201, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31959336
4.
Current status of immune checkpoint inhibition in early-stage NSCLC.
Ann Oncol
; 30(8): 1244-1253, 2019 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31143921
5.
Predictive biomarkers for response to EGFR-directed monoclonal antibodies for advanced squamous cell lung cancer.
Ann Oncol
; 29(8): 1701-1709, 2018 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29905778
6.
Geriatric Assessment and Functional Decline in Older Patients with Lung Cancer.
Lung
; 195(5): 619-626, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28634893
7.
Acquired resistance in NSCLC: the journey from clinical definition to molecular understanding.
Ann Oncol
; 32(12): 1463-1465, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34610278
8.
Metabolic phenotyping of human blood plasma: a powerful tool to discriminate between cancer types?
Ann Oncol
; 27(1): 178-84, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26487580
9.
Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upâ.
Ann Oncol
; 32(7): 839-853, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33864941
10.
Impact of KRAS codon subtypes from a randomised phase II trial of selumetinib plus docetaxel in KRAS mutant advanced non-small-cell lung cancer.
Br J Cancer
; 113(2): 199-203, 2015 Jul 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-26125448
11.
Cilengitide combined with cetuximab and platinum-based chemotherapy as first-line treatment in advanced non-small-cell lung cancer (NSCLC) patients: results of an open-label, randomized, controlled phase II study (CERTO).
Ann Oncol
; 26(8): 1734-40, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25939894
12.
Position of an international panel of lung cancer experts on the decision for expansion of approval for pembrolizumab in advanced non-small-cell lung cancer with a PD-L1 expression level of ≥1% by the USA Food and Drug Administration.
Ann Oncol
; 30(11): 1686-1688, 2019 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31504132
13.
2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up.
Ann Oncol
; 25(8): 1462-74, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24562446
14.
Will liquid biopsies become our fluid transition to personalized immunotherapy?
Ann Oncol
; 29(1): 11-13, 2018 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29165546
15.
Tyrosine kinase inhibition of EGFR: a successful history of targeted therapy for NSCLC since 20 years.
Ann Oncol
; 29(suppl_1): i1-i2, 2018 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29462258
16.
Genetic profiling of cell-free DNA from cerebrospinal fluid: opening the barrier to leptomeningeal metastasis in EGFR-mutant NSCLC.
Ann Oncol
; 29(4): 789-791, 2018 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29432543
17.
Randomized phase 2 trial on refinement of early-stage NSCLC adjuvant chemotherapy with cisplatin and pemetrexed versus cisplatin and vinorelbine: the TREAT study.
Ann Oncol
; 24(4): 986-92, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23161898
18.
Vaccination therapy for non-small-cell lung cancer: review of agents in phase III development.
Ann Oncol
; 23(6): 1387-93, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22156658
19.
Screening and early detection of lung cancer.
Ann Oncol
; 23 Suppl 10: x320-7, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22987984
20.
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Ann Oncol
; 28(suppl_4): iv1-iv21, 2017 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28881918